INmune Bio Inc. Presents Preclinical Data at SITC 2023 Showing INB03 is an Innate Immune Check Point Inhibitor that Downregulates SIRPα SIRP-CD47 is an innate immune checkpoint known as the “don’t eat me” signal. INB03 downregulates expression of SIRPα on macrophages promote increased cancer cell death by antibody dependent cellular...

Whittier Street Health Center Awarded a Grant to Expand Breast Cancer Services as Part of President's Reignited Cancer Moonshot, the Biden-Harris Administration Awards BOSTON, Feb. 09, 2023 (GLOBE NEWSWIRE) -- A $500,000 grant was awarded to Whittier Street Health Center to expand its breast cancer screening program, in partnership with Dana-Farber Cancer...

QT Imaging, Inc. Reaches New Milestones with Its Breakthrough Ultrasound Technology for Breast Imaging San Francisco, California, USA, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Last year, US Capital Global Securities LLC, an affiliate of US Capital Global, launched a convertible note offering of up to $30...

INmune Bio, Inc. Announces Key Breast Cancer Treatment Resistance Data to be Presented at the 2021 San Antonio Breast Cancer Symposium Data suggests in triple negative breast cancer that MUC4 predicts survival and resistance to immunotherapy and that INB03 reverses resistance by decreasing immunosuppression in the TME Boca...